BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 16048904)

  • 1. Enhancing cGMP in experimental progressive renal fibrosis: soluble guanylate cyclase stimulation vs. phosphodiesterase inhibition.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2006 Jan; 290(1):F167-76. PubMed ID: 16048904
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Stimulation of soluble guanylate cyclase slows progression in anti-thy1-induced chronic glomerulosclerosis.
    Wang Y; Krämer S; Loof T; Martini S; Kron S; Kawachi H; Shimizu F; Neumayer HH; Peters H
    Kidney Int; 2005 Jul; 68(1):47-61. PubMed ID: 15954895
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression and activity of soluble guanylate cyclase in injury and repair of anti-thy1 glomerulonephritis.
    Peters H; Wang Y; Loof T; Martini S; Kron S; Krämer S; Neumayer HH
    Kidney Int; 2004 Dec; 66(6):2224-36. PubMed ID: 15569311
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Low-dose mTOR inhibition by rapamycin attenuates progression in anti-thy1-induced chronic glomerulosclerosis of the rat.
    Krämer S; Wang-Rosenke Y; Scholl V; Binder E; Loof T; Khadzhynov D; Kawachi H; Shimizu F; Diekmann F; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2008 Feb; 294(2):F440-9. PubMed ID: 18094032
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pressure-independent effects of pharmacological stimulation of soluble guanylate cyclase on fibrosis in pressure-overloaded rat heart.
    Masuyama H; Tsuruda T; Sekita Y; Hatakeyama K; Imamura T; Kato J; Asada Y; Stasch JP; Kitamura K
    Hypertens Res; 2009 Jul; 32(7):597-603. PubMed ID: 19424280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nitric oxide-independent stimulation of soluble guanylate cyclase reduces organ damage in experimental low-renin and high-renin models.
    Sharkovska Y; Kalk P; Lawrenz B; Godes M; Hoffmann LS; Wellkisch K; Geschka S; Relle K; Hocher B; Stasch JP
    J Hypertens; 2010 Aug; 28(8):1666-75. PubMed ID: 20613628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activators and stimulators of soluble guanylate cyclase counteract myofibroblast differentiation of prostatic and dermal stromal cells.
    Zenzmaier C; Kern J; Heitz M; Plas E; Zwerschke W; Mattesich M; Sandner P; Berger P
    Exp Cell Res; 2015 Nov; 338(2):162-9. PubMed ID: 26410556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The lymphocyte migration inhibitor FTY720 attenuates experimental hypertensive nephropathy.
    Krämer S; Binder E; Loof T; Wang-Rosenke Y; Martini S; Khadzhynov D; Budde K; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2009 Jul; 297(1):F218-27. PubMed ID: 19439518
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pentoxifylline suppresses renal tumour necrosis factor-alpha and ameliorates experimental crescentic glomerulonephritis in rats.
    Chen YM; Ng YY; Lin SL; Chiang WC; Lan HY; Tsai TJ
    Nephrol Dial Transplant; 2004 May; 19(5):1106-15. PubMed ID: 14993492
    [TBL] [Abstract][Full Text] [Related]  

  • 10. cGMP stimulates renin secretion in vivo by inhibiting phosphodiesterase-3.
    Beierwaltes WH
    Am J Physiol Renal Physiol; 2006 Jun; 290(6):F1376-81. PubMed ID: 16449359
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mycophenolate mofetil slows progression in anti-thy1-induced chronic renal fibrosis but is not additive to a high dose of enalapril.
    Krämer S; Loof T; Martini S; Rückert M; Wang Y; Böhler T; Shimizu F; Kawachi H; Neumayer HH; Peters H
    Am J Physiol Renal Physiol; 2005 Aug; 289(2):F359-68. PubMed ID: 15769934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Desensitization of the soluble guanylyl cyclase/cGMP pathway by lipopolysaccharide in rat isolated pulmonary artery but not aorta.
    El-Awady MS; Smirnov SV; Watson ML
    Br J Pharmacol; 2008 Dec; 155(8):1164-73. PubMed ID: 18806822
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular mechanisms underlying rat mesenteric artery vasorelaxation induced by the nitric oxide-independent soluble guanylyl cyclase stimulators BAY 41-2272 [5-cyclopropyl-2-[1-(2-fluorobenzyl)-1H-pyrazolo[3,4-b]pyridin-3-yl]pyrimidin-4-ylamine] and YC-1 [3-(5'-hydroxymethyl-2'-furyl)-1-benzyl Indazole].
    Teixeira CE; Priviero FB; Webb RC
    J Pharmacol Exp Ther; 2006 Apr; 317(1):258-66. PubMed ID: 16352702
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pentoxifylline attenuates experimental mesangial proliferative glomerulonephritis.
    Chen YM; Chien CT; Hu-Tsai MI; Wu KD; Tsai CC; Wu MS; Tsai TJ
    Kidney Int; 1999 Sep; 56(3):932-43. PubMed ID: 10469361
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective lymphocyte inhibition by FTY720 slows the progressive course of chronic anti-thy 1 glomerulosclerosis.
    Peters H; Martini S; Wang Y; Shimizu F; Kawachi H; Krämer S; Neumayer HH
    Kidney Int; 2004 Oct; 66(4):1434-43. PubMed ID: 15458436
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Moderate alcohol intake has no impact on acute and chronic progressive anti-thy1 glomerulonephritis.
    Peters H; Martini S; Woydt R; Rückert M; Shimizu F; Kawachi H; Liefeldt L; Krämer S; Neumayer HH
    Am J Physiol Renal Physiol; 2003 May; 284(5):F1105-14. PubMed ID: 12676738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stimulation of soluble guanylate cyclase improves renal recovery after relief of unilateral ureteral obstruction.
    Wang-Rosenke Y; Mika A; Khadzhynov D; Loof T; Neumayer HH; Peters H
    J Urol; 2011 Sep; 186(3):1142-9. PubMed ID: 21784461
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nitric oxide-independent down-regulation of soluble guanylyl cyclase by bacterial endotoxin in astroglial cells.
    Baltrons MA; García A
    J Neurochem; 1999 Nov; 73(5):2149-57. PubMed ID: 10537075
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protective effects of BAY 41-2272 (sGC stimulator) on hypertension, heart, and cardiomyocyte hypertrophy induced by chronic L-NAME treatment in rats.
    Zanfolin M; Faro R; Araujo EG; Guaraldo AM; Antunes E; De Nucci G
    J Cardiovasc Pharmacol; 2006 Mar; 47(3):391-5. PubMed ID: 16633081
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-arginine and phosphodiesterase (PDE) inhibitors counteract fibrosis in the Peyronie's fibrotic plaque and related fibroblast cultures.
    Valente EG; Vernet D; Ferrini MG; Qian A; Rajfer J; Gonzalez-Cadavid NF
    Nitric Oxide; 2003 Dec; 9(4):229-44. PubMed ID: 14996430
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.